Antimicrobial use and incidence of multidrug-resistant pseudomonas aeruginosa in a teaching hospital: An ecological approach;Uso de antimicrobianos e incidência de pseudomonas aeruginosa multidroga-resistente em um hospital de ensino: Uma abordagem ecológica

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 43, Issue 6, 2010, Pages 629-632

  das Neves, Mariana Tresoldi ^a   de Lorenzo, Mariana Eliza Pinto ^a   Almeida, Ricardo Augusto Monteiro Barros ^a   Fortaleza, Carlos Magno Castelo Branco ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Antimicrobial resistance; Ecological study; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BRAZIL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DRUG USE; ECOLOGY; HUMAN; INCIDENCE; INFECTION CONTROL; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; TEACHING HOSPITAL; UNIVARIATE ANALYSIS;

PSEUDOMONAS AERUGINOSA;

EID: 78651079571     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822010000600005     Document Type: Article

References (15)

1. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert TM, Pollock DA, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29: 996-1011.
2. Ribeiro J, Mendes RE, Domingos R, França E, Silbert S, Jones RN, et al. Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: report from the SENTRY Antimicrobial Surveillance Program. J Chemother 2006; 18:461-467.
3. McGowan Jr JE. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Med 2006; 119(suppl 1):S29-36.
4. Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann MC. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 2002; 34:340-345.
5. Zavascki AP, Cruz RP, Goldani LZ. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients. J Hosp Infect 2005; 59:96-101.
6. Fortaleza CM, Freire MP, Filho D de C, de Carvalho Ramos M. Risk factors for recovery of imipenem-or ceftazidime-resistant Pseudomonas aeruginosa among patients admitted to a teaching hospital in Brazil. Infect Control Hosp Epidemiol 2006; 27:901-906.
7. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002; 8:347-354.
8. Natsch S, Hekster YA, de Jong R, Heerdink ER, Herings RM, van der Meer JW. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis 1998; 17: 20-24.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests; approved standard, 8th ed. Pennsylvania: CLSI; 2003.
10. Morgenstern H. Ecologic studies in epidemiology: concepts, principles and methods. Annu Rev Public Health 1995; 16:61-81.
11. Wakefield J. Ecologic studies revisited. Annu Rev Public Health 2008; 29:75-90.
12. Szklo M, Nieto FJ. Epidemiology-beyond the basics. Gaitheresburg: Aspen Publishers; 2000.
13. El Amari, EB Chamot E, Auckenthaler R, Pechere JC, Van Delden C. Influence of previous exposure to antibiotic on the susceptibility patterns of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis 2001; 33:1859-1864.
14. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibioticresistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 1999; 43:1379-1382.
15. rd. Antimicrobial resistance among gram-negative organisms in the intensive care unit. Curr Opin Crit Care 2003;9:413-423.